Timothy W Meyer Selected Research

Indican

1/2022	Impact of a 7-day homogeneous diet on interpersonal variation in human gut microbiomes and metabolomes.
12/2017	Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes.
1/2016	Effect of a sustained difference in hemodialytic clearance on the plasma levels of p-cresol sulfate and indoxyl sulfate.
1/2016	Tubular Secretion in CKD.
9/2014	Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients.
3/2014	Protein-bound molecules: a large family with a bad character.
5/2009	Sodium octanoate to reverse indoxyl sulfate and p-cresyl sulfate albumin binding in uremic and normal serum during sample preparation followed by fluorescence liquid chromatography.
7/2008	Relationship of impaired olfactory function in ESRD to malnutrition and retained uremic molecules.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Timothy W Meyer Research Topics

Disease

6	Chronic Kidney Failure (Chronic Renal Failure) 02/2017 - 11/2008
4	Renal Insufficiency (Renal Failure) 01/2022 - 02/2002
4	Cardiovascular Diseases (Cardiovascular Disease) 12/2017 - 11/2009
3	Chronic Renal Insufficiency 01/2018 - 05/2009
3	Proteinuria 08/2002 - 07/2000
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 12/2017 - 01/2017
2	Death (Near-Death Experience) 12/2017 - 01/2017
2	Uremia 02/2013 - 11/2008
2	Acute Kidney Injury (Acute Renal Failure) 08/2005 - 03/2004
2	Nephrosis 08/2002 - 07/2001
1	Pruritus (Itching) 01/2021
1	Sepsis (Septicemia) 02/2017
1	Infections 02/2017
1	Weight Gain 11/2016
1	Kidney Diseases (Kidney Disease) 01/2016
1	Anemia 07/2010
1	Malnutrition (Nutritional Deficiencies) 07/2008
1	Hyperglycemia 01/2006
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2006
1	Hydronephrosis 12/2005
1	Ureteral Obstruction 12/2005
1	Hypertension (High Blood Pressure) 02/2002
1	Infarction (Infarctions) 02/2002
1	Fibrosis (Cirrhosis) 07/2000
1	Sclerosis 07/2000
1	Ischemia 07/2000

Drug/Important Bio-Agent (IBA)

8	IndicanIBA 01/2022 - 07/2008
7	4-cresol sulfateIBA 01/2022 - 07/2008
3	trimethyloxamine (trimethylamine N-oxide)IBA 01/2018 - 01/2015
2	phenylacetylglutamineIBA 01/2022 - 12/2017
2	hippuric acidIBA 12/2017 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 05/2009
2	Losartan (Cozaar)FDA LinkGeneric 02/2002 - 07/2000
2	Enalapril FDA LinkGeneric 02/2002 - 07/2000
1	Serum AlbuminIBA 12/2017
1	Phosphates (Orthophosphate)IBA 11/2016
1	cinnamoylglycineIBA 01/2016
1	Essential Amino AcidsIBA 05/2014
1	Urea (Carbamide)FDA LinkGeneric 01/2013
1	Sulfates (Sulfates, Inorganic)IBA 05/2009
1	EnzymesIBA 11/2008
1	Uremic ToxinsIBA 11/2008
1	Hormones (Hormone)IBA 11/2008
1	methylamine (methylammonium)IBA 07/2008
1	ethylamineIBA 07/2008
1	Streptozocin (Streptozotocin)FDA Link 01/2006
1	Blood Glucose (Blood Sugar)IBA 01/2006
1	Complementary DNA (cDNA)IBA 03/2004
1	Dihydrotachysterol (AT 10)IBA 08/2002
1	PuromycinIBA 08/2002
1	AngiotensinsIBA 02/2002
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2002
1	Peptides (Polypeptides)IBA 02/2002
1	ReninIBA 02/2002
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 02/2002
1	BradykininIBA 02/2002
1	Antihypertensive Agents (Antihypertensives)IBA 02/2002
1	AldosteroneIBA 02/2002
1	Type 1 Angiotensin ReceptorIBA 02/2002
1	Nifedipine (Adalat)FDA LinkGeneric 02/2002
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2001
1	Angiotensin IIIBA 07/2000

Therapy/Procedure

6	Renal Dialysis (Hemodialysis) 01/2021 - 01/2013
4	Therapeutics 11/2016 - 02/2002
3	Nephrectomy 12/2005 - 07/2000
1	Hemofiltration 08/2005
1	Continuous Renal Replacement Therapy 08/2005